Uncategorized - August 21, 2013
Digital reality at Digital Health Days
As the Digital Health Days had its first of a two-day event, it was clear that the digital healthcare revolution is not a future happening but already a fact. Representatives from the life science industry, the healthcare sector as well as the academia gathered at the Stockholm fair just outside of the capital to engage […]
Agreement - August 20, 2013
Sectra signs deal with British hospital
Spire Roding Hospital, part of the private healthcare group Spire, will be the first hospital in the Spire group to use Sectra’s online service to identify osteoporotic fractures at an early stage. “Osteoporosis can be an under-diagnosed disease and there is great need for simple, cost-effective methods of identifying patients in need of treatment. Being able […]
Pharma article - August 16, 2013
In-house or outsource?
Not only in the Nordic countries, but also in the rest of Europe, pharmaceutical companies are choosing to locate their R&D activities in emerging markets. What are the drug company strategies and what effect will the ongoing outsourcing trend have on the industry? China India, Russia, and South American countries such as Brazil, are highly […]
Drug development - August 16, 2013
Genovis evaluates new diagnosis technology
Genovis has signed an agreement with Respiratorius to evaluate a new technology for the early diagnosis of cardiovascular disease. The agreement involves tests and evaluation of RESP-3000 as a new biomarker for early diagnosis of cardiovascular disease using PET-imaging. The final evaluation will be conducted by GeccoDots AB, Genovis’ wholly owned subsidiary. According to a […]
Intellectual Property - August 12, 2013
Pharmalundensis acquires patent
Pharmalundensis has acquired a patent application to use metabotropic glutamate receptors in group 1 for prevention of intra abdominal adhesions encountered after surgery. The project was started by Redeco Chem, a company based in Lund, south of Sweden and its collaboration partners. Pharmalundensis will during the fall of 2013 carry out further studies to evaluate the effects. Should the […]
Biotech Business - August 12, 2013
Artimplant files for bankruptcy
Gothenburg-based biomaterial company Artimplant has filed for bankruptcy. The company announced the news after being sued by up to 50 patients in the US, which claim to have been injured when using the company’s products. As a consequence of the bankruptcy, 12 employees in Gothenburg will be affected. According to a company press release, the […]
